Firefly Neuroscience is trading 5.5% up at $1.15, though the catalyst for the move remains unclear.
- No company-specific announcement dated August 17, 2026, was identified.
- Recent coverage includes second-quarter results reported August 11 and an August 5 update on higher TMS-center brain-scan volumes; neither source explicitly links those developments to the move.
- Broader indexes are slightly lower.